Your browser doesn't support javascript.
loading
The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study.
Chen, Delphine L; Huang, Howard J; Byers, Derek E; Shifren, Adrian; Belikoff, Bryan; Engle, Jacquelyn T; Arentson, Elizabeth; Kemp, Debra; Phillips, Sharon; Scherrer, David E; Fujiwara, Hideji; Spayd, Katherine J; Brooks, Frank J; Pierce, Richard A; Castro, Mario; Isakow, Warren.
Afiliação
  • Chen DL; Mallinckrodt Institute of Radiology, Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Huang HJ; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Byers DE; Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center at Dallas, Dallas, TX, United States of America.
  • Shifren A; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Belikoff B; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Engle JT; Mallinckrodt Institute of Radiology, Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Arentson E; Mallinckrodt Institute of Radiology, Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Kemp D; Mallinckrodt Institute of Radiology, Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Phillips S; Center for Clinical Studies, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Scherrer DE; Mallinckrodt Institute of Radiology, Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Fujiwara H; Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Spayd KJ; Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Brooks FJ; Mallinckrodt Institute of Radiology, Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Pierce RA; Mallinckrodt Institute of Radiology, Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Castro M; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Isakow W; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, United States of America.
PLoS One ; 13(2): e0191783, 2018.
Article em En | MEDLINE | ID: mdl-29414995
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Araquidonato 5-Lipoxigenase / Tiazolidinedionas / Receptores Ativados por Proliferador de Peroxissomo / Hidroxiureia Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Araquidonato 5-Lipoxigenase / Tiazolidinedionas / Receptores Ativados por Proliferador de Peroxissomo / Hidroxiureia Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos